Literature DB >> 22365738

MicroRNAs and hematopoietic cell development.

Ryan M O'Connell1, David Baltimore.   

Abstract

Hematopoiesis is a dynamic and highly complex developmental process that gives rise to a multitude of the cell types that circulate in the blood of multicellular organisms. These cells provide tissues with oxygen, guard against infection, prevent bleeding by clotting, and mediate inflammatory reactions. Because the hematopoietic system plays such a central role in human diseases such as infections, cancer, autoimmunity, and anemia, it has been intensely studied for more than a century. This scrutiny has helped to shape many of the developmental paradigms that exist today and has identified specific protein factors that serve as master regulators of blood cell lineage specification. Despite this progress, many aspects of blood cell development remain obscure, suggesting that novel layers of regulation must exist. Consequently, the emergence of regulatory noncoding RNAs, such as the microRNAs (miRNAs), is beginning to provide new insights into the molecular control networks underlying hematopoiesis and diseases that stem from aberrations in this process. This review will discuss how miRNAs fit into our current understanding of hematopoietic development in mammals and how breakdowns in these pathways can trigger disease. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22365738     DOI: 10.1016/B978-0-12-387038-4.00006-9

Source DB:  PubMed          Journal:  Curr Top Dev Biol        ISSN: 0070-2153            Impact factor:   4.897


  35 in total

1.  MiR-23b is a safeguard against autoimmunity.

Authors:  Ruozhen Hu; Ryan M O'Connell
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

2.  MicroRNAs contribute to induced pluripotent stem cell somatic donor memory.

Authors:  Marianna Vitaloni; Julian Pulecio; Josipa Bilic; Bernd Kuebler; Leopoldo Laricchia-Robbio; Juan Carlos Izpisua Belmonte
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

Review 3.  MicroRNAs in myeloproliferative neoplasms.

Authors:  Huichun Zhan; Christopher Cardozo; Azra Raza
Journal:  Br J Haematol       Date:  2013-02-25       Impact factor: 6.998

Review 4.  MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.

Authors:  K Musilova; M Mraz
Journal:  Leukemia       Date:  2014-12-26       Impact factor: 11.528

Review 5.  miRNA-transcription factor interactions: a combinatorial regulation of gene expression.

Authors:  S Arora; R Rana; A Chhabra; A Jaiswal; V Rani
Journal:  Mol Genet Genomics       Date:  2013-01-20       Impact factor: 3.291

Review 6.  Long noncoding RNAs in biology and hematopoiesis.

Authors:  Vikram R Paralkar; Mitchell J Weiss
Journal:  Blood       Date:  2013-05-03       Impact factor: 22.113

Review 7.  MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts.

Authors:  Jared A Wallace; Ryan M O'Connell
Journal:  Blood       Date:  2017-07-27       Impact factor: 22.113

8.  Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs.

Authors:  Magdalena Kozakowska; Krzysztof Szade; Jozef Dulak; Alicja Jozkowicz
Journal:  Antioxid Redox Signal       Date:  2014-01-30       Impact factor: 8.401

Review 9.  MicroRNA 155 and viral-induced neuroinflammation.

Authors:  Laura L Dickey; Timothy M Hanley; Thomas B Huffaker; Andrew G Ramstead; Ryan M O'Connell; Thomas E Lane
Journal:  J Neuroimmunol       Date:  2017-01-24       Impact factor: 3.478

Review 10.  The role of chromatin modifiers in normal and malignant hematopoiesis.

Authors:  Jill S Butler; Sharon Y R Dent
Journal:  Blood       Date:  2013-01-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.